EARLY platform combines the skills of the LYSARC dedicated team and the LYSA experts center network to conduct early phase lymphoma trials.
The LYSA center network includes early-phase centers (“CLIP2″) accredited by the French National Cancer Institute (INCa).
This platform for the realization of phase I/IIa clinical trials, in cooperation with industry. conducts:
• first-in man studies,
• first-in-lymphoma studies,
• first combo studies.
About twelve LYSA centers are available for phase I trials and more than thirty LYSA centers for phase II trials.
LYSARC has a large experience in lymphoma early clinical development with more than 40 trials so far.